Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Editorial Board

Dr Ophira Ginsburg

New York University School of Medicine, United States of America

Ophira Ginsburg is a medical oncologist with expertise in cancer epidemiology, prevention and screening, and a primary focus in women’s health equity and global cancer control. She is a fellow of the Royal College of Physicians and Surgeons (Canada), a Scientist at Women’s College Hospital and Research Institute, and holds academic appointments at the University of Toronto, the James P Grant School of Public Health at BRAC University, Bangladesh, and the Institute of Cancer Policy at King’s Health Partners, London UK. She has been an advisor to the National Institute for Cancer Control of Vietnam, a member of the Technical Advisory Committee of the GTF.CCC and the UICC Global Task Force on Radiotherapy for Cancer Control. Over the past 12 years she has developed an innovative program of population intervention research, education, and policy initiatives in cancer disparities and global cancer control, with projects in North America, Vietnam, Bangladesh, and more recently, in Tanzania. The overarching goal of her academic work is to inform resource appropriate practices and policy to reduce health inequities for women with cancer.

In October 2015 she became a Technical Officer in the Noncommunicable Diseases Management Unit, NVI Department at World Health Organization Headquarters in Geneva. Her duties were to help build their policy and programming for women’s cancers, including guidance, recommendations, and implementation frameworks on breast cancer prevention, early detection/screening and management in collaboration with the WHO International Agency for Research on Cancer (IARC), with other UN organizations such as IAEA and UNFPA, international experts and partners building upon existing WHO and IARC breast cancer related documents.

She has recently joined NYU Langone’s Perlmutter Cancer Center as director of its new High Risk Program, which identifies, studies and cares for patients with hereditary syndromes that increase cancer risk.

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation